Reata Pharmaceuticals
Latest round
- Series F
Last raised
- Apr 2009
Total raised
- $79M
Investors
- 7
About Reata Pharmaceuticals
Reata Pharmaceuticals, Inc. specializes in the development of therapeutic agents targeting serious medical conditions. The company was founded in 2002 and is headquartered in Plano, Texas, US. Founded by Philip Thomas, Reata has undergone strategic decisions to enhance its product pipeline without any noted pivots or changes in business operations.70 mn.Reata Pharmaceuticals focuses on innovative therapies for serious neurological and rare diseases. Their primary products include agents that modulate cellular pathways related to oxidative stress and inflammation, addressing conditions like Friedreich's ataxia and Alport syndrome.Reata Pharmaceuticals is strategizing for future growth by focusing on the launch of new therapies aimed at addressing unmet medical needs in rare diseases. The company is committed to utilizing its resources effectively to expand its reach and enhance its therapeutic offerings for patients by 2018.
Who invested in Reata Pharmaceuticals
7 investors across 4 rounds
See all investors in Reata Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Reata Pharmaceuticals
Who invested in Reata Pharmaceuticals?
Reata Pharmaceuticals has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reata Pharmaceuticals raised?
Reata Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Reata Pharmaceuticals last raise money?
Reata Pharmaceuticals's most recent round on record is a Series F, in Apr 2009.
What does Reata Pharmaceuticals do?
Reata Pharmaceuticals is a biotechnology company.
Where is Reata Pharmaceuticals headquartered?
Reata Pharmaceuticals is headquartered in Plano, US.
Which VCs invest in companies like Reata Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Reata Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Reata Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.